TC BioPharm (Holdings) plc·4

Jan 11, 3:30 PM ET

Randall Mark Edward 4

4 · TC BioPharm (Holdings) plc · Filed Jan 11, 2023

Insider Transaction Report

Form 4
Period: 2022-11-30
Transactions
  • Purchase

    Series A Warrants

    2022-11-30+70,00070,000 total(indirect: By Renaissance Capital Partners Ltd)
    Exercise: $5.00From: 2022-11-30Exp: 2028-05-30Ordinary Shares (70,000 underlying)
  • Purchase

    Series B Warrants

    2022-11-30+70,00070,000 total(indirect: By Renaissance Capital Partners Ltd)
    Exercise: $5.00From: 2022-11-30Exp: 2025-05-30Ordinary Shares (70,000 underlying)
  • Purchase

    Ordinary Shares [ADS]

    2022-11-30$5.00/sh+70,000$350,000382,963 total(indirect: By Renaissance Capital Partners Ltd)
Holdings
  • Ordinary Shares [ADS]

    9,952
  • Warrants

    (indirect: By Renaissance Capital Partners Ltd)
    Exercise: $4.25From: 2022-04-11Exp: 2028-02-10Ordinary Shares (106,129 underlying)
    106,129
Footnotes (2)
  • [F1]Series A Warrants were issued as a part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.
  • [F2]Series B Warrants were issued as a part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of $5.00.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT